Company filings profile · CIK 0002019410
Caris Life Sciences, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Caris Life Sciences, Inc. (CAI): 22 filings in the last 90 days vs 17 in the prior 90 (filing-velocity rising ↑ · 1.29×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Nov 5, 2026. Source-linked, daily-refreshed.
Material 8-K events — Caris Life Sciences, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Nov 4, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Sep 14, 2026 | Regulation FD Disclosure | ↗ |
| Aug 5, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 5, 2026 | Item 5.07 | ↗ |
Watch Caris Life Sciences, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Nov 4, 2026 | 10-Q | 10-Q | ↗ |
| Nov 4, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Sep 23, 2026 | 4 | FORM 4 | ↗ |
| Sep 22, 2026 | 144 | ↗ | |
| Sep 17, 2026 | 4 | FORM 4 | ↗ |
| Sep 17, 2026 | 144 | ↗ | |
| Sep 14, 2026 | 8-K | Regulation FD Disclosure | ↗ |
| Sep 4, 2026 | 4 | FORM 4 | ↗ |
| Sep 4, 2026 | 144 | ↗ | |
| Sep 3, 2026 | 144 | ↗ | |
| Aug 24, 2026 | 144 | ↗ | |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 12, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 7, 2026 | 144 | ↗ | |
| Aug 7, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 5, 2026 | 10-Q | 10-Q | ↗ |
| Aug 5, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 3, 2026 | 144 | ↗ | |
| Jul 13, 2026 | 4 | FORM 4 | ↗ |
| Jun 16, 2026 | CERT | NYSE TEXAS CERTIFICATION | ↗ |
| Jun 16, 2026 | 8-A12B | FORM 8-A12B | ↗ |
| Jun 5, 2026 | 8-K | Item 5.07 | ↗ |
| Jun 2, 2026 | 4 | FORM 4 | ↗ |
| Jun 2, 2026 | 4 | FORM 4 | ↗ |
| May 18, 2026 | 4 | FORM 4 | ↗ |
| May 18, 2026 | 4 | FORM 4 | ↗ |
| May 18, 2026 | 4 | FORM 4 | ↗ |
| May 18, 2026 | 4 | FORM 4 | ↗ |
| May 18, 2026 | 4 | FORM 4 | ↗ |
| May 12, 2026 | SCHEDULE 13G/A | ↗ | |
| May 12, 2026 | SCHEDULE 13G/A | ↗ | |
| May 12, 2026 | 4 | FORM 4 | ↗ |
| May 8, 2026 | 10-Q | 10-Q | ↗ |